Estimating the number of symptomatic SARS-CoV-2 infections among vaccinated individuals in the United States—January–July, 2021

As of March 2021, three COVID-19 vaccines had been authorized by the U.S. Food and Drug Administration (FDA) for use in the United States. Each has substantial efficacy in preventing COVID-19. However, as efficacy from trials was <100% for all three vaccines, disease in vaccinated people is expec...

Descripción completa

Detalles Bibliográficos
Autores principales: Kugeler, Kiersten J., Williamson, John, Curns, Aaron T., Healy, Jessica M., Nolen, Leisha D., Clark, Thomas A., Martin, Stacey W., Fischer, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906607/
https://www.ncbi.nlm.nih.gov/pubmed/35263352
http://dx.doi.org/10.1371/journal.pone.0264179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906607/
https://www.ncbi.nlm.nih.gov/pubmed/35263352
http://dx.doi.org/10.1371/journal.pone.0264179

Ejemplares similares